The Latest Breaking News from StockNews.com

The software industry has shown resilience, consistent growth, innovation, and adaptability to changing market demands and emerging technologies. Given the industry’s solid growth prospects, fundamentally strong software stocks Workday (WDAY), Akamai Technologies (AKAM), and Smartsheet (SMAR) could be ideal additions to your portfolio. Read on.

Battery electric vehicle (BEV) makers are grappling with a demand slowdown, changing consumer preferences, chip shortages, a surge in demand for hybrid vehicles, and sales challenges. Amid this uncertain backdrop, will automakers Tesla, Inc. (TSLA) and NIO Inc. (NIO) stage a recovery? Let’s discuss.

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more.

With the rapidly growing demand for personalized medicine, innovative solutions, and recent developments like AI in drug discovery, the biotech industry's prospects appear robust. Thus, quality biotech stocks Vertex Pharmaceuticals (VRTX), SIGA Technologies (SIGA), and Gilead Sciences (GILD) could be ideal candidates to buy now. Read more….

Investors may have celebrated the end of high inflation too soon. The CPI report shows inflation bouncing higher and thus pushing back the start date for Fed rate cuts. This has the S&P 500 (SPY) coming off recent highs. This begs questions like how much more downside could we see?…

The energy sector is expected to grow significantly due to geopolitical tensions, supply constraints, and rising global demand for natural gas and crude oil. Therefore, fundamentally strong energy stocks Enterprise Products Partners (EPD), Koninklijke Vopak (VOPKY), and VAALCO Energy (EGY) could be worth adding to your portfolio. Read on.

The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that end, affordable pharma stocks ACADIA Pharmaceuticals (ACAD), Astellas Pharma (ALPMY), and Spero Therapeutics (SPRO), trading under $20, could be solid buys now. Read on….

The telecom industry is poised for significant expansion, driven by rising demand for high-speed connectivity, ongoing innovations, and the rapid growth of 5G networks. Therefore, for portfolio diversification, investors could consider buying fundamentally strong telecom stocks Orange (ORAN), América Móvil (AMX), and KT Corporation (KT). Read more.

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading.

Tesla (TSLA) reported a decline in deliveries in the first quarter, and Wall Street expects the company to deliver fewer vehicles than last year. Furthermore, rising competition, slowing EV sales, and stretched valuation make TSLA unattractive from an investment standpoint. Considering these factors, investors could consider buying fundamentally strong auto…

The software industry's prospects appear bright due to increasing investments in digital transformation, high demand for advanced software services from various sectors, and the integration of emerging technologies such as generative AI. Therefore, investors could consider buying quality software stocks Autodesk (ADSK), DocuSign (DOCU), and Pegasystems (PEGA) for solid gains.…